Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership $12.50 +0.58 (+4.87%) (As of 09:07 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$12.03 M Get RCKT Insider Trade Alerts Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RCKT Insider Buying and Selling by Quarter Ad WealthPressIs the Trump/Musk duo good for shares of TSLA?If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Rocket Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/21/2024Gaurav ShahCEOSell11,091$13.05$144,737.55 11/21/2024John MilitelloInsiderSell1,224$13.05$15,973.20 11/21/2024Martin WilsonGeneral CounselSell1,175$13.05$15,333.75 7/22/2024John MilitelloInsiderSell812$23.02$18,692.24 7/8/2024Mark Andrew WhiteInsiderSell3,026$20.39$61,700.14 5/16/2024Gaurav ShahCEOSell9,790$23.35$228,596.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2024John MilitelloInsiderSell1,079$23.35$25,194.65 5/16/2024Martin WilsonGeneral CounselSell1,048$23.35$24,470.80 4/22/2024John MilitelloInsiderSell833$22.87$19,050.71 4/15/2024David P SouthwellDirectorSell10,000$24.05$240,500.00 4/12/2024David P SouthwellDirectorSell70,000$24.36$1,705,200.00 4/8/2024Mark Andrew WhiteInsiderSell12,532$24.64$308,788.48 3/21/2024Gotham MakkerDirectorSell274,000$28.43$7,789,820.00 3/21/2024John MilitelloInsiderSell2,490$28.10$69,969.00 2/29/2024John MilitelloInsiderSell10,000$29.84$298,400.00 2/29/2024Martin WilsonGeneral CounselSell4,100$29.33$120,253.00 2/16/2024Gaurav ShahCEOSell20,272$29.84$604,916.48 2/16/2024Kinnari PatelInsiderSell7,132$29.84$212,818.88 2/16/2024Martin WilsonGeneral CounselSell3,576$29.84$106,707.84 1/22/2024John MilitelloInsiderSell638$27.20$17,353.60 (Data available from 1/1/2013 forward) RCKT Insider Trading Activity - Frequently Asked Questions Who is on Rocket Pharmaceuticals's Insider Roster? The list of insiders at Rocket Pharmaceuticals includes David P Southwell, Gaurav Shah, Gotham Makker, John Militello, Jonathan David Schwartz, Kinnari Patel, Mark Andrew White, Martin Wilson, and Rtw Investments, Lp. Learn more on insiders at RCKT. What percentage of Rocket Pharmaceuticals stock is owned by insiders? 28.50% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings. Which Rocket Pharmaceuticals insiders have been selling company stock? The following insiders have sold RCKT shares in the last 24 months: David P Southwell ($1,945,700.00), Gaurav Shah ($1,284,413.66), Gotham Makker ($8,457,281.36), John Militello ($528,837.73), Jonathan David Schwartz ($67,796.42), Kinnari Patel ($236,549.86), Mark Andrew White ($370,488.62), and Martin Wilson ($266,765.39). How much insider selling is happening at Rocket Pharmaceuticals? Insiders have sold a total of 500,661 Rocket Pharmaceuticals shares in the last 24 months for a total of $13,157,833.04 sold. Rocket Pharmaceuticals Key ExecutivesMs. Kinnari Patel M.B.A. (Age 44)Pharm.D., Head of R&D, President & COO Compensation: $849.93kMr. Mayo Pujols (Age 54)Chief Technical Officer Compensation: $649.71kMr. Raj Prabhakar M.B.A. (Age 49)Chief Business Officer Compensation: $619.13kMr. Aaron Ondrey (Age 47)Chief Financial Officer Mr. Martin Louis Wilson J.D. (Age 48)General Counsel, Chief Compliance Officer & Chief Corporate Officer Compensation: $149.95kKevin GiordanoDirector of Corporate CommunicationsMs. Isabel Carmona J.D.Chief People OfficerMr. Jonathan Schwartz M.D. (Age 59)Chief Medical & Gene Therapy Officer Compensation: $557.79kDr. Gayatri R. Rao J.D.M.D., Senior VP of Clinical Safety & Chief Regulatory OfficerMr. Carlos MartinChief Commercial Operations & Revenue Officer More Insider Trading Tools from MarketBeat Related Companies Ultragenyx Pharmaceutical Insider Ownership Biohaven Insider Ownership Apellis Pharmaceuticals Insider Ownership Immunovant Insider Ownership Scholar Rock Insider Ownership Avidity Biosciences Insider Ownership Organon & Co. Insider Ownership PTC Therapeutics Insider Ownership Verona Pharma Insider Ownership Rhythm Pharmaceuticals Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:RCKT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
